1673-422X
2012 Issue 6
DNA methylation in Barrett esophagus and esophageal adenocarcinoma
LI Bo;LING Zhi-qiang;MAO Wei-min
LI Bo;LING Zhi-qiang;MAO Wei-min
..............page:439-442
The role of amplified in breast family and their research mechanisms in ovarian cancer
WANG Lian;LI Cong-zhu;ZHANG Hao
WANG Lian;LI Cong-zhu;ZHANG Hao
..............page:452-454
..............page:后插2
Hypofractionated radiotherapy for non-small-cell lung cancer
GUAN Shang-hui;LI Cai-yun;CHENG Yu-feng
GUAN Shang-hui;LI Cai-yun;CHENG Yu-feng
..............page:436-439
Breast cancer molecular subtypes and its clinical significance
YU Shuang-quan;YU Zhi-yong
YU Shuang-quan;YU Zhi-yong
..............page:432-435
Roles of SUMOylation and de-SUMOylation in carcinogenesis
HU Dan;CHEN Fu-xiang
HU Dan;CHEN Fu-xiang
..............page:406-408
Roles of cancer stem cells in tumor angiogenesis
ZHANG Xiao-yue;ZHANG Wei-dong
ZHANG Xiao-yue;ZHANG Wei-dong
..............page:403-405
Roles of the liver regeneration phosphatase-3 and its inhibitors in tumor
WANG Wen-juan;HE Tai-ping
WANG Wen-juan;HE Tai-ping
..............page:415-417
Effect of cyclooxygenase-2 inhibitor in anti-leukemia
XIE Xia;HAO Hong-ling
XIE Xia;HAO Hong-ling
..............page:462-464
Chemoprevention of plant polyphenols in gastric cancer
LIU Ru-miag;JIANG Jing;MA Lin;CAO Xue-yuan
LIU Ru-miag;JIANG Jing;MA Lin;CAO Xue-yuan
..............page:442-445
Cancer and venous thromboembolism
SHI Zhi-yong;ZHANG Yi-ping
SHI Zhi-yong;ZHANG Yi-ping
..............page:455-458
Clinical study of ocular damnification after intensity-modulated radiotherapy in patients with nasopharyngeal carcinoma
LI Yan-Jie;LIU Hai-yan;WANG Yan-yan;WANG Li-cang;ZHAO Chang-qing
LI Yan-Jie;LIU Hai-yan;WANG Yan-yan;WANG Li-cang;ZHAO Chang-qing
..............page:472-476
Toxicities of targeted therapy in renal cancer and their treatment strategies
WU Xiao-rong;LIU Dong-ming
WU Xiao-rong;LIU Dong-ming
..............page:445-448
Mechanism and prevention in cancer complicated with deep venous thrombosis of lower limbs
HONG Gu-qi;CHEN Guo-fen
HONG Gu-qi;CHEN Guo-fen
..............page:458-461
Establishment of ovarian SKOV3 cell line stably expressing PES1 by Tet-on inducible system
LI Jie-ping;ZHUANG Qin-ren;LAN Xiao-peng;ZENG Guo-bin;LUO Xiao-feng
LI Jie-ping;ZHUANG Qin-ren;LAN Xiao-peng;ZENG Guo-bin;LUO Xiao-feng
..............page:465-468
Tumor microenvironment related type 17 T helper cells
WANG Hui;LI Jie;HUA Bao-jin;SUN Gui-zhi
WANG Hui;LI Jie;HUA Bao-jin;SUN Gui-zhi
..............page:418-421
Molecular markers of cancer and individualized therapy
GU Fei-ying;YUAN Ying
GU Fei-ying;YUAN Ying
..............page:428-431
Negative regulation of transforming growth factor-β superfamily co-receptor Ⅲ in tumorigenesis
ZHANG Shu-sheng;ZHANG Biao;WANG Jin-huan
ZHANG Shu-sheng;ZHANG Biao;WANG Jin-huan
..............page:411-414
Effect of serum autoantibodies in the early diagnosis of cancer
PENG Yu-hui;XU Yi-wei
PENG Yu-hui;XU Yi-wei
..............page:425-428
Antitumor effect of inhibitor of growth 4
ZHAO Da-hang;WANG Bao-xin;WANG Wen-bo
ZHAO Da-hang;WANG Bao-xin;WANG Wen-bo
..............page:422-424
Autophagy and invasion and metastasis in malignant tumor
WENG Jun-quan;HOU Jin-song
WENG Jun-quan;HOU Jin-song
..............page:408-411
Significance of MALAT1, COX-2, β-catenin, MMP-3 and MMP-9 in the occurrence and development of colorectal carcinoma
JI Qing;ZHOU Ning;LIU Xuan;YIN Pei-hao;QIN Jian-ming;LI Qi
JI Qing;ZHOU Ning;LIU Xuan;YIN Pei-hao;QIN Jian-ming;LI Qi
..............page:477-480
Application of diffusion-weighted imaging in the diagnosis and treatment of cervical cancer
FU Chun;FENG Xiao-yan;WANG Xiang-quan;ZHAO Yan
FU Chun;FENG Xiao-yan;WANG Xiang-quan;ZHAO Yan
..............page:449-452
Synergy effects of octreotide combined with cisplatin and 5-fluorouracil on inhibition of lung adenocarcinoma cell line A549
PAN Jin-kun;LI Bao-ping;ZHANG Lei;REN Hong-wei;XU Feng
PAN Jin-kun;LI Bao-ping;ZHANG Lei;REN Hong-wei;XU Feng
..............page:469-472